KW-2450_TherAdvMedOncol_Additional_file_5Apr2018 – Supplemental material for Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole

Autor:	Umehara, Hiroshi, Maekawa, Yoshimi, Fumito Koizumi, Shimizu, Makiko, Ota, Toshio, Fouad, Tamer M., Willey, Jie, Hidekuni Kaito, Norihiko Shiraishi, Nakashima, Daisuke, Akinaga, Shiro, Ueno, Naoto T.
Rok vydání:	2018
Předmět:	110203 Respiratory Diseases FOS: Clinical medicine 111702 Aged Health Care FOS: Health sciences 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 111299 Oncology and Carcinogenesis not elsewhere classified
DOI:	10.25384/sage.6881663.v1
Popis:	Supplemental material, KW-2450_TherAdvMedOncol_Additional_file_5Apr2018 for Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole by Hiroshi Umehara, Yoshimi Maekawa, Fumito Koizumi, Makiko Shimizu, Toshio Ota, Tamer M. Fouad, Jie Willey, Hidekuni Kaito, Norihiko Shiraishi, Daisuke Nakashima, Shiro Akinaga and Naoto T. Ueno in Therapeutic Advances in Medical Oncology
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e5a0355b09c488a68f5e6fcb8a291b Zobrazit plný text záznamu